← Mechanisms of action
BCMA
SINGLE PROTEINHomo sapiens
Drugs acting on this target (95)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| abbv-383 | Binding agent | experimental | mAb | BCMA |
| bms-986405 | Binding agent | experimental | mAb | BCMA binding agent |
| ciltacabtagene autoleucel (Carvykti) | Binding agent | approved | Cell therapy | BCMA binding agent |
| cm-336 | Binding agent | experimental | mAb | BCMA binding agent |
| Elranatamab (Elrexfio) | Binding agent | approved | mAb | BCMA binding agent |
| f182112 | Binding agent | experimental | mAb | BCMA binding agent |
| gr1803 | Binding agent | experimental | mAb | BCMA binding agent |
| idecabtagene vicleucel (Abecma) | Binding agent | approved | Small molecule | BCMA binding agent |
| isb 2001 | Binding agent | experimental | mAb | BCMA binding agent |
| jnj-79635322 | Binding agent | experimental | mAb | BCMA binding agent |
| tqb2934 | Binding agent | experimental | mAb | BCMA |
| wvt078 | Binding agent | experimental | Cell therapy | BCMA binding agent |
| act-001 car-nk cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| allo-605 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| anti-bcma/cd70 car-t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| anti-bcma/gprc5d car-t cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| ari0003 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma car-nk 92 cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma-cd19-il-15/il-15 sushi compound car t | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma-cs1 ccar t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma-pd1-cart cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma-tgfβ car-t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma/cd19 dual-target car-t | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma/cd70-targetd car-t | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma/fcrl5 car t | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bcma/gprc5d double car-t | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| brl-302 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| bze2204 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| c-car168 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cb-011 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cbg002 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cc-92328 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cc-98633 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cd19/bcma hi-tcr-t cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cd19/cd20/bcma car t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cd20/bcma-directed car-t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cd38 and bcma car-t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cesnicabtagene autoleucel | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| chimeric antigen receptor t cell o&d-001 injection targeting bcma and gprc5d | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| ct0594cp | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| cxcr4 modified anti-bcma car t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| descartes 11 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| descartes-11 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| descartes-15 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| descartes-25 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| equecabtagene autoleucel (Fucacell) | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| eso-t01 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| fcarh143 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| ft576 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| gc012f | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| hbi0101 cart | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| IBI-346 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| im21 car-t cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| jcarh125 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| jnj-68284528 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| kln-1010 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| kq-2003 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| lcar-b38m car-t cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| lcar-b4822m car-t cell | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| lcar-bcdr cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| lcar-bcx | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| lucar-b68 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| mcarh125 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| mdc-car-bcma001 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| mdc-car-bcma001 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| nanobody-based biepitope bcma-targeting car-t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| neuk203-215 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| nxc-201 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| ol-101 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| oriv508 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| p-bcma-allo1 car-t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| phe885 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| prg-1801 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| prg-2311 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| sys6020 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| tripril car t cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| uf-kure-bcma car t-cells | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| universal bcma car-t | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| utaa17 | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| uwd-00b | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| v001-bcma | Immunity, passive | experimental | Cell therapy | BCMA immunity, passive |
| abbv-243 | Inhibitor | experimental | mAb | BCMA inhibitor |
| bcd-248 | Inhibitor | experimental | mAb | BCMA inhibitor |
| bms-986453 | Inhibitor | experimental | mAb | BCMA inhibitor |
| cm336 | Inhibitor | experimental | mAb | BCMA inhibitor |
| ibi3003 | Inhibitor | experimental | mAb | BCMA inhibitor |
| kt501 | Inhibitor | experimental | mAb | BCMA inhibitor |
| mbs314 | Inhibitor | experimental | mAb | BCMA inhibitor |
| om336 | Inhibitor | experimental | mAb | BCMA inhibitor |
| rn1101 | Inhibitor | experimental | mAb | BCMA inhibitor |
| rn1201 | Inhibitor | experimental | mAb | BCMA inhibitor |
| sar445514 | Inhibitor | experimental | mAb | BCMA inhibitor |
| sim0500 | Inhibitor | experimental | mAb | BCMA inhibitor |
| wgb-0302 | Inhibitor | experimental | Nucleic acid | BCMA inhibitor |
| ykst02 | Inhibitor | experimental | mAb | BCMA inhibitor |